{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-21-000058","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2021-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.539274+00:00","generated_at":"2026-06-30T05:47:58.672353+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Immunovant CFO Pamela Yanchik Connealy resigns effective July 16; transition consulting through Sept 9","bullets":["CFO Pamela Yanchik Connealy resigned effective July 16, 2021; no reason given.","She will provide transition consulting services through expected annual meeting (~Sept 9, 2021) at $375/hour.","Consulting agreement filed as Exhibit 10.1; she reports to CEO Peter Salzmann.","No immediate replacement for CFO named; transition period ends at annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-21-000058","json":"https://secwatch.observer/filing/0001764013-21-000058.json","markdown":"https://secwatch.observer/filing/0001764013-21-000058.md","text":"https://secwatch.observer/filing/0001764013-21-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000058/0001764013-21-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000058/imvt-20210707.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T05:47:58.672353+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91018d3e2a","claim":"Pamela Yanchik Connealy resigned as Chief Financial Officer at Immunovant, Inc..","evidence_excerpt":"On July 7, 2021, Pamela Yanchik Connealy, the Chief Financial Officer of Immunovant, Inc., resigned from Immunovant, such resignation to be effective on July 16, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000058/0001764013-21-000058-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}